2018 ASH Annual Meeting - Education Program
Description
As the premier event in malignant and non-malignant hematology, the ASH annual meeting provides attendees with an outstanding educational experience that examines the latest clinical advances in hematology and explores the year's most significant scientific discoveries and updates. The videos make this event available for convenient, on-demand viewing.
ASH offers four package options, where you can choose between scientific and educational content, purchase both at a lower price, or purchase the complete meeting including oral abstracts.
The 2018 ASH Annual Meeting Education Program package includes all of the following sessions:
• General Sessions
• Education Program Sessions
• Special-Interest Sessions
• Spotlight Sessions
• Trainee Simultaneous Didactic Sessions
Access the 2018 ASH Annual Meeting – Invited plus Oral Abstracts for all webcast sessions.
ASH offers four package options, where you can choose between scientific and educational content, purchase both at a lower price, or purchase the complete meeting including oral abstracts.
The 2018 ASH Annual Meeting Education Program package includes all of the following sessions:
• General Sessions
• Education Program Sessions
• Special-Interest Sessions
• Spotlight Sessions
• Trainee Simultaneous Didactic Sessions
Access the 2018 ASH Annual Meeting – Invited plus Oral Abstracts for all webcast sessions.
Pricing
| Member Type | Price |
|---|---|
| List Price | $350.00 |
| Active, International, Emeritus, and Honorary Members | $225.00 |
| Associate, International Associate, Student, and Resident Members | $100.00 |
Sessions
Education Program
- A Panoply of Immunotherapies for Adult B-Lineage Acute Lymphocytic Leukemia
- Acute Myeloid Leukemia: Moving Beyond 7+3
- Aggressive Lymphomas
- Anxiety-Provoking Consults: Macrophage Activation Syndrome, Castleman Disease, and Hypereosinophilia
- Approach to the Treatment of the Older, Unfit Patient With Myeloma: From Diagnosis to Relapse
- Approach to the Treatment of the Young, Fit Patient With Myeloma: From Diagnosis to Relapse
- As If Myeloproliferative Neoplasms Weren't Already Challenging Enough
- AYA: Big Children or Small Adults? Leukemia Treatment in Adolescence
- Chronic Myeloid Leukemia: With Great Success Comes Great Responsibility
- Delivering High-Quality Oral Anticoagulant Therapy: State of the Art in 2018
- Follicular Lymphoma: Have We Made Progress?
- Hemolytic Anemia: A Cornucopia of Causes
- Hemostatic and Thromboembolic Challenges in the Young
- High-Performance Hematology: Elite Athletes and Weekend Warriors
- Hodgkin Lymphoma: Beyond ABVD for Everyone
- Junior Faculty Career-Development Session
- Long-Term Management of VTE: The First Six Months and Beyond
- Reining in Graft-Versus-Host Disease (GVHD) After Allogeneic Hematopoietic Cell Transplantation
- Severe Aplastic Anemia: Diagnosis and Management in an Era of Effective Therapies
- Sickle Cell Disease: New Frontiers
- Thalassemia Syndromes: Diagnosis and Management in a Changing World
- The Future of Chronic Lymphocytic Leukemia (CLL) Therapy
- The Interface Between Man and Machine: Managing Hemostasis and Thrombosis in the Plastic and Metal Circulation
- The Molecular Maelstrom of Myelodysplastic Syndromes (MDS)
- Thrombotic Thrombocytopenic Purpura (TTP) 2019: State of the Art
- Update in Transfusion Therapy for Hematologic Malignancies: Transfusion Support – TACO and TRALI
- Using Genomics to Risk Stratify and Treat Kids
- What's Hot in Immune Thrombocytopenic Purpura (ITP)?
General Sessions
- Announcement of Awards: Wallace H. Coulter Award for Lifetime Achievement in Hematology, ASH Mentor Awards, ASH Award for Leadership in Promoting Diversity, ASH Outstanding Service Award, and ASH Public Service Award
- Announcement of Awards: William Dameshek Prize and Henry M. Stratton Medal
- ASH-EHA Joint Symposium
- Best of ASH
- E. Donnall Thomas Lecture and Prize
- Ernest Beutler Lecture and Prize
- Ham-Wasserman Lecture
- Late-Breaking Abstracts Session
- Plenary Scientific Session
- Presidential Symposium
- State of the Society Address
Special Scientific Symposia
Special-Interest Sessions
- ASH Choosing Wisely® Campaign: 2018 ASH Choosing Wisely Champions
- ASH-FDA Joint Symposium on New Drug Approvals I
- ASH-FDA Joint Symposium on New Drug Approvals II
- Blood and Beyond: Cancer- what it does to you AND for you
- Featured Topic: Novel Therapies and Taxonomy in Lymphoid Neoplasms: Are We Ready for the Shift?
- Featured Topic: Sickle Cell Disease: New Drugs, Curative Approaches
- Global Hematology Symposium
- MDS + AML MATTER: A Multidisciplinary Approach to Testing and Diagnosis, Evaluation of Risk, and Personalized Treatment Selection
- Social Media for the Hematologist: Today and in the Future
- Special Education Session on ASH Clinical Practice Guidelines on Sickle Cell Disease
- Special Education Session on ASH Clinical Practice Guidelines on Venous Thromboembolism
- Special Session with the National Cancer Institute Director
- Special Symposium on ASH-Supported Researchers
- Special Symposium on Quality
- Systems-Based Hematology Education and Networking Session
Spotlight Sessions
- Biochemical and Genetic Insights Into MLL/11q23 Translocation Leukemia
- Hemophilia: A Disease in Transition
- Leukemia Predisposition Syndromes
- Managing Acute and Chronic Pain in Patients With Sickle Cell Disease
- Myeloproliferative Neoplasms (MPN) Roundtable: How Will We Cure Myelofibrosis?
- New Insights Into Neonatal Hematology: Not Just a Small Adult
- Population Risks of Developing Myeloid Malignancies
- The Story Is the Story: Using Narrative Medicine to Cure Disease
Trainee Activities and Services
ASH Meeting on Hematologic Malignancies
Hear the latest developments in clinical care, and get answers to your most challenging patient care questions.
Learn more
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
Copyright © 2021 by American Society of Hematology